The lower expression level of MEF2D in brain regions with more ReHo increment in migraine may support the hypothesis that abnormalities in brain glucose metabolism generate a mismatch between the brain's energy reserve and metabolic expenditure (Del Moro et al., 2022), which may lead to ReHo increment in migraine. This evidence concerns the gene MEF2D and migraine disorder.